BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 29578068)

  • 1. Generation and evaluation of a recombinant Newcastle disease virus strain R2B with an altered fusion protein cleavage site as a vaccine candidate.
    Yadav K; Pathak DC; Saikia DP; Debnath A; Ramakrishnan S; Dey S; Chellappa MM
    Microb Pathog; 2018 May; 118():230-237. PubMed ID: 29578068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of a recombinant chimeric Newcastle disease virus vaccine that allows serological differentiation between vaccinated and infected animals.
    Peeters BP; de Leeuw OS; Verstegen I; Koch G; Gielkens AL
    Vaccine; 2001 Feb; 19(13-14):1616-27. PubMed ID: 11166884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions.
    Palya V; Kiss I; Tatár-Kis T; Mató T; Felföldi B; Gardin Y
    Avian Dis; 2012 Jun; 56(2):282-7. PubMed ID: 22856183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of fusion protein cleavage site sequence on generation of a genotype VII Newcastle disease virus vaccine.
    Manoharan VK; Varghese BP; Paldurai A; Samal SK
    PLoS One; 2018; 13(5):e0197253. PubMed ID: 29758054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenicity and immunogenicity of different recombinant Newcastle disease virus clone 30 variants after in ovo vaccination.
    Ramp K; Topfstedt E; Wäckerlin R; Höper D; Ziller M; Mettenleiter TC; Grund C; Römer-Oberdörfer A
    Avian Dis; 2012 Mar; 56(1):208-17. PubMed ID: 22545548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics.
    Hu S; Ma H; Wu Y; Liu W; Wang X; Liu Y; Liu X
    Vaccine; 2009 Feb; 27(6):904-10. PubMed ID: 19095026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation by reverse genetics of an effective, stable, live-attenuated newcastle disease virus vaccine based on a currently circulating, highly virulent Indonesian strain.
    Xiao S; Nayak B; Samuel A; Paldurai A; Kanabagattebasavarajappa M; Prajitno TY; Bharoto EE; Collins PL; Samal SK
    PLoS One; 2012; 7(12):e52751. PubMed ID: 23285174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype-matched Newcastle disease virus vaccine confers improved protection against genotype XII challenge: The importance of cytoplasmic tails in viral replication and vaccine design.
    Izquierdo-Lara R; Chumbe A; Calderón K; Fernández-Díaz M; Vakharia VN
    PLoS One; 2019; 14(11):e0209539. PubMed ID: 31725727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel genotype VII Newcastle disease virus vaccine candidate generated by mutation in the L and F genes confers improved protection in chickens.
    Ji Y; Liu T; Du Y; Cui X; Yu Q; Wang Z; Zhang J; Li Y; Zhu Q
    Vet Microbiol; 2018 Mar; 216():99-106. PubMed ID: 29519533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel recombinant attenuated Newcastle disease virus expressing H9 subtype hemagglutinin protected chickens from challenge by genotype VII virulent Newcastle disease virus and H9N2 avian influenza virus.
    Xu X; Xue C; Liu X; Li J; Fei Y; Liu Z; Mu J; Bi Y; Qian J; Yin R; Ding Z
    Vet Microbiol; 2019 Jan; 228():173-180. PubMed ID: 30593364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine.
    Esaki M; Godoy A; Rosenberger JK; Rosenberger SC; Gardin Y; Yasuda A; Dorsey KM
    Avian Dis; 2013 Dec; 57(4):750-5. PubMed ID: 24597117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rescue of a recombinant Newcastle disease virus strain R2B expressing green fluorescent protein.
    Chellappa MM; Dey S; Gaikwad S; Pathak DC; Vakharia VN
    Virus Genes; 2017 Jun; 53(3):410-417. PubMed ID: 28185139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of phylogenetic diversity of velogenic Newcastle disease virus challenge on virus shedding post homologous and heterologous DNA vaccination in chickens.
    Mohamed MH; Abdelaziz AM; Kumar S; Al-Habib MA; Megahed MM
    Avian Pathol; 2016; 45(2):228-34. PubMed ID: 26813237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and evaluation of a genetically attenuated Newcastle disease virus rGM-VIIm as a genotype-matched vaccine.
    Sun M; Xiang B; Li Y; Xie P; Gao S; Kang Y; Gao P; Li Y; Wang Z; Liang J; Yu D; Ren T
    Virus Genes; 2017 Feb; 53(1):35-43. PubMed ID: 27718047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of fusion protein cleavage site sequences of Newcastle disease virus in genotype matched vaccines.
    Kim SH; Chen Z; Yoshida A; Paldurai A; Xiao S; Samal SK
    PLoS One; 2017; 12(3):e0173965. PubMed ID: 28339499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A recombinant Newcastle disease virus (NDV) expressing infectious laryngotracheitis virus (ILTV) surface glycoprotein D protects against highly virulent ILTV and NDV challenges in chickens.
    Kanabagatte Basavarajappa M; Kumar S; Khattar SK; Gebreluul GT; Paldurai A; Samal SK
    Vaccine; 2014 Jun; 32(28):3555-63. PubMed ID: 24793943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant infectious bronchitis virus (IBV) H120 vaccine strain expressing the hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) protects chickens against IBV and NDV challenge.
    Yang X; Zhou Y; Li J; Fu L; Ji G; Zeng F; Zhou L; Gao W; Wang H
    Arch Virol; 2016 May; 161(5):1209-16. PubMed ID: 26873815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Chicken Interferon Gamma on Newcastle Disease Virus Vaccine Immunogenicity.
    Cardenas-Garcia S; Dunwoody RP; Marcano V; Diel DG; Williams RJ; Gogal RM; Brown CC; Miller PJ; Afonso CL
    PLoS One; 2016; 11(7):e0159153. PubMed ID: 27409587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newcastle disease virus (NDV) marker vaccine: an immunodominant epitope on the nucleoprotein gene of NDV can be deleted or replaced by a foreign epitope.
    Mebatsion T; Koolen MJ; de Vaan LT; de Haas N; Braber M; Römer-Oberdörfer A; van den Elzen P; van der Marel P
    J Virol; 2002 Oct; 76(20):10138-46. PubMed ID: 12239288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant NDV expressing cytokines or fliC confers a quick immune response against NDV challenge and resistance to maternal antibody.
    Zhang T; Liu Y; Wang H; Zhang X; Zhu S; Xu P; Yin J; Ren G; Liu J; Li D
    Vet Microbiol; 2016 Nov; 196():107-117. PubMed ID: 27939146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.